#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia recurrent Central nervous system lymphoma Transitional cell cancer of the renal pelvis and ureter Gastrointestinal disorder Non-small cell lung cancer Restless legs syndrome Phenylketonuria Ischaemic stroke Primary adrenal insufficiency Dent's disease Scleroderma associated digital ulcer Gaucher's disease type III Duchenne muscular dystrophy Osteosarcoma metastatic Myelin oligodendrocyte glycoprotein antibody-associated disease More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Basic Information Fragile X syndrome – Life with Disease Ornithine transcarbamoylase deficiency – Trials in Disease Prolymphocytic leukaemia – Treatment Angiosarcoma recurrent – Trials in Disease Osteosarcoma – Diagnostics Usher’s syndrome Hyperoxaluria – Basic Information Inclusion body myositis – Trials in Disease Netherton’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ATIRMOCICLIB ZUNIBERGENE ROCPARVOVEC Platelet Concentrate Tiapride POLYSORBATE 80 Spironolactone Neratinib Nemtabrutinib Ezabenlimab Vinorelbine Tartrate ETX-19477 Dexibuprofen Zidesamtinib HYDROXYCHLOROQUINE Bbp-398 Mycophenolate Sodium Tipranavir Tyrosine Perampanel Clopidogrel Hydrogen Sulfate More therapies…

    Learn about Your Condition

    Peritoneal neoplasm Carotid artery stenosis Obstructive pancreatitis Monkeypox Testicular leiomyosarcoma Tricuspid valve disease Bladder cancer stage II Synovial sarcoma recurrent Dyslipidaemia Biliary adenoma Haemorrhoids Chordoma Neuralgia Left ventricular dysfunction Still's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Sodium Lactate and Electrolyte Solution in Comatose Patients After Cardiac Arrest

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    • Post cardiac arrest syndrome
    • Reperfusion injury
    Investigated Drugs:
    • Sodium Lactate
    • Magnesium Chloride Hexahydrate
    • Potassium Chloride
    Belgium

  • Study of pegcetacoplan safety and effectiveness in adolescents aged 12-17 with paroxysmal nocturnal hemoglobinuria

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Pegcetacoplan
    The Netherlands Spain

  • Study on Esketamine Hydrochloride and Sodium Chloride for Patients with Severe Acute Brain Injury

    Recruiting

    3 1 1
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Sodium Chloride
    Denmark

  • Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Vidofludimus Calcium
    Bulgaria Czechia Germany The Netherlands Poland Romania

  • Study on Cluster Headache Using Befiradol (18F) for Patients with Episodic Symptoms

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Befiradol (18F)
    France

  • Study of Ipilimumab, Nivolumab and Melphalan combination therapy with hepatic perfusion in patients with advanced uveal melanoma that has spread to other organs

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Melphalan
    • Ipilimumab
    • Nivolumab
    The Netherlands
Previous Page
1 … 365 366 367 368 369 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!